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Abstract
The opioid system influences learning and memory processes. However, neural mechanisms underlying the modulation of
hippocampal activity by opioid receptors remain largely unknown. Here, we compared how mu and delta receptors operate
within the mouse CA1 network, and used knock-in mice expressing functional delta opioid receptors fused to the green
fluorescent protein (DOR-eGFP) to determine how delta opioid receptor-expressing interneurons integrate within the
hippocampal circuitry. Through whole cell patch-clamp recording of CA1 pyramidal neurons from wild-type and DOR-eGFP
mice, we found that mu and delta receptors both modulate spontaneous GABAergic inhibition received by these cells.
Interestingly, mu but not delta receptor activation decreased the feed-forward inhibitory input evoked by Schaffer collateral
stimulation. However, mu and delta agonists modulated GABAergic feed-forward inhibition when evoked upon stimulation
of the temporoammonic pathway. In addition, anterograde tracing using biotinylated dextran amine injected into the
entorhinal cortex of DOR-eGFP mice suggests the existence of synaptic contacts between temporoammonic afferents and
delta receptor-expressing interneurons processes in CA1. Altogether, our data demonstrate a distinct modulatory role of the
hippocampal network activity by mu and delta opioid receptors, and show for the first time that delta receptor-expressing
interneurons in the CA1 are recruited by the temporoammonic pathway rather than the Schaffer collateral.
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Introduction
The opioid system plays a major role in the control of
nociceptive pathways, modulates affective behavior [1], and is
also involved in learning and memory processes [2,3]. Mu
receptors are the primary molecular target of morphine and
mediate its effects on memory-related behaviors [4,5] whereas
delta opioid receptors are involved in spatial memory [6] as well as
drug-context associations [7,8] or context-induced reinstatement
to drug seeking [9,10]. All these studies point to a crucial role of
mu and delta opioid receptors as modulators of hippocampal
activity.
In rats, immunohistochemical [11–13], in situ hybridization [14]
and electrophysiological [15,16] data showed that mu and delta
opioid receptors are mainly expressed in hippocampal GABAergic
interneurons. Recently, a similar distribution was reported for
murine delta receptors using DOR-eGFP knock-in mice that
express delta receptors fused at their C-terminus to the green
fluorescent protein (GFP) [17,18].
From a functional point of view, opioid receptors indirectly
modulate principal cell activity. In rats, application of mu or delta
opioid agonists disinhibits CA1 pyramidal cells by decreasing
GABA release from interneurons. However, only mu but not delta
receptor activation decreases the GABAergic feed-forward inhibi-
tion activated upon Schaffer collateral (SC) stimulation on rat
hippocampal slices [15]. This suggests that the neuronal popula-
tions expressing mu and delta opioid receptors are differently
integrated within the CA1 network. Hence, delta receptor-
expressing population could possibly be contacted by other
hippocampal inputs such as the temporoammonic pathway (TA),
another major entry to the CA1 that originates in the entorhinal
cortical layer III [19].
Here, we combined electrophysiological recording of CA1
pyramidal cells, anterograde tracing of the TA and direct
visualization of delta opioid receptor subcellular localization in
DOR-eGFP knock-in mice to examine the recruitment of delta
opioid receptor-expressing neurons by the SC and the TA
pathways.
Methods
Ethics Statement
All experiments were performed in accordance with the
European Communities Council Directive (26/05/2010) and
approved by the local ethical committee (Com’Eth 2010-003).
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Animals
DOR-eGFP knock-in mice (n = 37) expressing the delta opioid
receptor fused to GFP were generated as described previously [20]
and used separately when stated or pooled with wild-type animals
(n = 11). Mice deficient for the delta opioid receptor (DOR-KO,
n=5) [21] were used to verify agonist specificity in figure 1C.
Animals were housed in a temperature- and humidity-controlled
animal facility (2162uC, 4565% humidity) on a 12 h dark-light
cycle with food and water ad libitum. Male and female mice (C57/
BL6J;129svPas 50:50%) aged 3–4 weeks (electrophysiology) or 12
weeks (tracing) were used.
Acute Hippocampal Slice Preparation
Animals (3–4 weeks) were killed by cervical dislocation and
brains quickly placed into « slicing ice-cold artificial cerebrospinal
fluid (saCSF) » containing (in mM): 126 NaCl, 2.5 KCl, 2.7
MgCl2, 1.2 NaH2PO4, 26 NaHCO3, 10 glucose, 1 CaCl2, 0.01
MK801 for classical preparation, or 130 K-Gluconate, 14 KCl,
2 EGTA, 20 HEPES, 25 glucose, 0.01 MK801 for the potassium-
gluconate protocol. Solutions were bubbled with 95%O2/
5%CO2. 300 mm coronal or horizontal sections (12u angle,
anterior side of the brain to the apex) were cut with a vibratome
(Leica VT1000S) for experiments respectively involving SC or TA
stimulation. Hippocampal slices were then incubated for 30 min at
34uC in MK801-free saCSF or 10 min for the potassium-
gluconate protocol in a solution containing (in mM): 225 D-
Mannitol, 2.3 KCl, 7.7 MgCl2, 1.25 NaH2PO4, 25 NaHCO3, 25
glucose, 0.5 CaCl2. For experiments in the presence of an opioid
antagonist, naltrexone 100 mg/kg was injected intraperitoneally
30 minutes before sacrificing the animal and downstream
manipulations were performed in solutions containing 10 mM
naltrexone. For experiments involving sucrose, 150 mM sucrose
was added in the saCSF and the NaCl concentration was only
40 mM. Before being used for electrophysiology, slices were
Figure 1. Influence of acute slice preparation protocols on receptor subcellular localization and basal interneuron activity in the
CA1 area. A: Representative confocal images showing DOR-eGFP membrane localization after slicing (slicing) (left panels) and DOR-eGFP subcellular
distribution following the recovery period preceding electrophysiological recordings (recovery) (right panels) in the four protocols used. Scale bars
10 mm. B: Quantification of DOR-eGFP internalization expressed as a ratio of membrane associated versus cytoplasmic fluorescence densities (n = 8–
14). DOR-eGFP plasma membrane localization is preserved in the presence of sucrose 150 mM (sucrose) or upon sodium chloride substitution by
potassium gluconate (High K+) but not in classical slice preparation protocol (classical), nor in the presence of the antagonist naltrexone 10 mM (NTX).
*, p,0,05 versus baseline, ***, p,0,001 compared to classical; #, p,0,05, ###, p,0,001 compared to slicing. C: Representative traces showing the
difference in sIPSCs frequency recorded in CA1 pyramidal cell using the classical, sucrose or High K+ slice preparation protocol. Scale bar: 500 ms/
50 pA. D: Histogram showing the difference of sIPSCs frequency recorded in CA1 pyramidal cell in different conditions. Frequency is significantly
lower in DOR-eGFP KI mice slices prepared in the presence of 150 mM sucrose (sucrose, n = 4) than in aCSF (classical, n = 4) or upon sodium chloride
substitution by potassium gluconate (K+ gluconate, n = 11). *, p,0.05 compared to classical. In the latter condition basal frequencies are not different
in DOR-eGFP KI, wild type and DOR KO mice. Application of the delta opioid receptor agonist deltorphin II (500 nM) induces a comparable and
washable decrease in DOR-eGFP KI and wild type but has no effect in DOR KO mice.
doi:10.1371/journal.pone.0079081.g001
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allowed to recover at room temperature for 1 h in oxygenated
aCSF containing (in mM): 126 NaCl, 3 KCl, 1.2 MgCl2, 1.2
NaH2PO4, 25 NaHCO3, 25 glucose, 1.3 CaCl2. All chemicals
were from Sigma-Aldrich (St Louis, MO, USA) except QX-314
(Merck, Darmstadt, Germany).
Electrophysiological Recordings
All experiments were conducted on pyramidal cells of the
hippocampal CA1 region identified by their morphology. Slices
were observed under infrared Nomarski optics using a 636water
immersion objective and a Hamamatsu C8484 camera mounted
on a Leica DMLFSA microscope. In the patch setup, the slice was
continuously perfused with bubbled aCSF at 2 mL.min21 and
drugs (500 nM deltorphin II, 500 nM DAGO, 2 mM Kynur-
enate, 50 mM CNQX and APV) were added through bath
application or locally by 10 second pressure injections (picosprit-
zer, Parker, Cleveland, USA).
Whole-cell voltage clamp recordings of membrane currents
were made using patch electrodes (4–6 MV) pulled from
GC150TF borosilicate glass capillaries (Sutter Instruments) on a
horizontal puller (Zeitz Instrumente, Munich, Germany) and filled
with intracellular solutions containing (in mM): 140 cesium
methane-sulfonate, 10 HEPES, 1 CaCl2, 3 MgSO4, 3 ATP-Na2,
0.5 GTP-Na3, 10 EGTA, 5 QX-314, 0.07 AlexaFluorH 568
hydrazide (Molecular Probes, Saint-Aubin, France), osmolarity
318 mOsm/L, pH adjusted to 7.3 with CsOH). The junction
potential (14 mV) was compensated online; series resistance (15–
40 MV) was not compensated but monitored during the whole
recording (calculated from the exponential decrease of the
capacitive current induced by a 10 mV step imposed to the cell
every 2 min) and only if stable, were cells kept for statistical
analysis. Membrane currents were acquired using a Multiclamp
700 A amplifier, a Digidata 1322A interface and the pCLAMP9
software (Molecular Devices, Sunnyvale, CA, USA). Spontaneous
and evoked inhibitory post-synaptic currents (sIPSCs and eIPSCs,
respectively) were isolated by holding cells at the reversal potential
of non selective cationic currents (+10 mV), while a holding
potential of 270 mV, corresponding to the reversal potential of
GABA-evoked current, was used to isolate evoked excitatory post-
synaptic currents (eEPSCs). sIPSCs were filtered (1 kHz low-pass
filter) and sampled at 2 kHz for later off-line analysis (pCLAMP).
Events were automatically detected by a sliding-template algo-
rithm, manually checked and counted to construct time plots of
the sIPSCs frequencies and amplitudes. eIPSCs or eEPSCs were
evoked using bipolar tungsten microelectrodes (0.5 MV) connected
to a constant current isolated stimulator (DS3, Digitimer ltd.,
Hertfordshire, England) and placed either between CA1 and CA2
area in the stratum radiatum for SC stimulation, or at the
subiculum level in the stratum lacunosum moleculare for TA
stimulation.
Imaging of Acute Hippocampal Slice
Slices were taken for imaging either directly after slicing
(named slicing) or at the end of the recovery period just before
starting recording (named recovery). Recovery period was 90
minutes (30 minutes recovery at 34uC followed by 1 hour at
room temperature in a) for the classical a, sucrose and
naltrexone protocols and 70 min for the high K+ protocol
(10 min recovery in mannitol solution at 34uC followed by 1 h
in aCSF at room temperature). Slices were fixed in 4%
paraformaldehyde, 0.1 M phosphate buffer saline pH 7.3 (PBS),
washed 3 times in PBS for 10 min and mounted in Mowiol
with 49, 6-diamidino-2-phenylindole (DAPI).
Anterograde Tracing
12-week old mice were anesthetized with Ketamine/Xylazine
(100/10 mg/kg, i.p.) and maintained in a stereotaxic frame. The
skin above the skull was disinfected and opened with a single
scalpel cut of 2 cm. The skull was washed with PBS and a 1 mm
diameter hole was drilled in the appropriate location. 0.2 M
potassium acetate containing 4% biotinylated dextran amine
(BDA, Invitrogen) was unilaterally delivered into the layer III of
the entorhinal cortex (stereotaxic coordinates (mm): LM +4.1; AP
23; DV +5.2) using a glass micropipette (tip diameter: 10–30 mm)
and iontophoretically injected (4 mA current, 7 seconds ON/7
seconds OFF during 20 minutes, Midgard source, Stoelting). The
cut was stitched up, lidocain cream was applied on the wound and
animals were taken out of the stereotaxic frame and put on a 35uC
plate to recover. The whole procedure typically lasted less than 45
minutes and the mice usually recovered within 15 minutes after
the surgery. Animals were sacrificed 2–15 days later and perfused
with 10 mL 0.1 M phosphate buffer pH 7.3 (PB) followed by
50 mL of 4% paraformaldehyde in PB. Dissected brains were
post-fixed in 4% paraformaldehyde in PB overnight and cut with a
vibratome (Leica VT1000S) in 60 mm slices. DOR-eGFP signal
was amplified by immunochemistry as described previously [17]
and BDA revealed with AlexaFluorH 594 conjugated streptavidin
(1:2000) (Molecular Probes).
Image Acquisition and Fluorescence Quantification
Samples were observed with a confocal microscope (SP2, Leica)
with a 406oil objective and images acquired with the LCS (Leica)
software. The method used for image analysis was as described in
Scherrer et al. (2006). Briefly, quantification of internalization was
performed using the IMAGEJ software. Nuclear fluorescence
defined the background level. Cytosolic fluorescence intensity was
subtracted from whole cell fluorescence intensity to obtain surface
fluorescence intensity. Fluorescence intensity values were divided
per surface unit (pixel) to obtain densities. Ratio of surface (Df surf)
versus cytoplasmic (Df cyto) fluorescence densities was calculated
to normalize data across neurons examined. A value of 1.0 results
from equal densities of DOR-EGFP at the cell surface and in the
cytoplasm. For each condition, four animals were used. Two slices
per animal and 1–2 neurons per slice were analyzed for surface
versus intracellular DOR-eGFP distribution.
Statistical Analysis
Effect of slice preparation on DOR-eGFP localization was
assessed using a two-way ANOVA and a Newman-Keuls post-hoc
test. Non-parametric test were chosen instead of ANOVA for
electrophysiology experiments to account for the small size of the
sampling. For comparisons involving genotype effects, Mann-
Whitney tests with Holm-Bonferroni corrections were performed,
whereas significance of drugs effects and washout were tested with
the repeated measure Friedman rank test and a Newman-Keuls
post-hoc test. Latencies of eEPSC vs eIPSC were compared using
paired t-test.
Results
Acute Slice Preparation Strongly Impacts on Delta Opioid
Receptor Subcellular Localization
Using DOR-eGFP knock-in mice, we previously showed that,
in vivo, delta opioid receptors are localized at the plasma
membrane in the basal state and internalize in intracellular
vesicles upon activation by an agonist [20,22]. Imaging hippo-
campal slices immediately after slicing by fluorescence microscopy
confirmed DOR-eGFP localization at the cell surface (Fig. 1A).
Opioid Receptor Expressing Neurons in CA1 Network
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However, after slice recovery in aCSF as used for patch-clamp
recordings, most DOR-eGFP fluorescence was detected intracel-
lularly (Fig. 1A&B). Different protocols were then tested to
preserve delta receptor plasma membrane localization.
We first examined whether addition of the opioid antagonist
naltrexone (100 mg/kg i.p. followed by 10 mM in saCSF and
aCSF) would be sufficient to prevent receptor internalization.
Unfortunately, this approach proved inefficient to maintain the
receptor at the plasma membrane (Fig. 1A&B).
We then attempted to block delta receptor internalization via
clathrin-coated pits by adding sucrose at all steps of the slice
preparation [23–25]. Low concentration (75 mM) was inefficient
(not shown) whereas high concentrations (150 mM), though
preserving cell surface localization (Fig. 1A&B), deeply affected
neuronal survival. Indeed, observation of the surface of the slice
under Nomarski optics showed numerous swelled cells with
reduced refringence, their nuclei becoming clearly visible.
Moreover, recording of CA1 pyramidal cells revealed extremely
low sIPSC frequency (2.060.8 Hz, n= 4) compared to slices
prepared in classical conditions (6.161.5 Hz, n= 4) (Fig. 1B).
We finally tested a strategy in which the electrical activity in the
slice would be temporarily decreased by substituting sodium
chloride with potassium-gluconate [26]. This protocol, designed to
keep cells slightly hyperpolarized when returned to normal aCSF
following slice cutting, preserved DOR-eGFP cell surface locali-
zation (Fig. 1A&B) and resulted in high, stable sIPSC frequency
values (10.361.5 Hz, n= 11) (Fig. 1C). This protocol was chosen
for all subsequent experiments, as they involved DOR stimulation.
To further control our experimental conditions, basal frequen-
cies and effect of the delta opioid receptor agonist deltorphin II
were compared in wild type, DOR-eGFP and DOR knockout
mice. Basal sIPSC frequencies were not significantly different
between DOR-eGFP (10.361.5 Hz, n= 11), wild type
(7.861.3 Hz, n= 8) and DOR knock-out mice (10.461.8 Hz,
n = 5), indicating no effect from deletion or mutation of the delta
opioid receptor on basal GABAergic inhibition received by
pyramidal cells. Application of the selective delta agonist
deltorphin II (500 nM) decreased the baseline sIPSC frequency
by 49.5611.7% in DOR-eGFP mice (n = 7) and by 38.467.0% in
wild type mice (n = 4) with no modification in DOR knock-out
mice (8.0613.6%, n= 5) (Fig. 1C). Since sIPSC frequencies and
response to delta opioid agonist were no significantly different
between DOR-eGFP and wild-type mice, data from both
genotypes were pooled in subsequent experiments.
The Schaffer Collateral Pathway Recruits mu but not
Delta Opioid Receptor-expressing Interneurons
Application of the selective mu agonist DAGO (500 nM) or
delta agonist deltorphin II (500 nM) both decreased sIPSC
frequencies (by 51.265.6% (n= 6) and 44.963.8% (n= 9)
respectively) (Fig. 2A & 2C). DAGO and Deltorphin II
(500 nM) had no significant effect on sIPSC amplitude (decreased
by 21.968.9 (n = 6) and 17.267.2 (n = 9) respectively) and no
effect on holding current was observed. Data are in good
agreement with previously published results obtained from rats
[15,27].
We then focused on opioid modulation of interneurons
recruited by the SC. Upon SC stimulation, we performed
whole-cell recording of CA1 pyramidal cells held at the reversal
potential of EPSC (+10 mV) or IPSC (270 mV), resulting in the
isolation of eIPSC and eEPSC, respectively. Analysis of evoked
currents peak latencies revealed statistically shorter latencies for
eEPSC (6.7861.13 ms) than for eIPSC (10.7361.85 ms,
p = 0.018), as expected for mono-synaptic excitation and di-
synaptic (feed-forward) inhibition.
Application of DAGO (500 nM) decreased eIPSC amplitude by
42.365.4% (n= 6) (Fig. 2B). However, deltorphin II (500 nM)
failed to induce a significant decrease in eIPSC amplitude
(8.167.5%, n= 9) (Fig. 2B). Our data therefore suggest that, in
mice, SC afferents recruit mu but not delta opioid receptor-
expressing interneurons.
The Temporoammonic Pathway Recruits both Mu and
Delta Opioid Receptor Expressing Interneurons
Recent evidence points to an implication of the TA pathway in
spatial memory [28]. Also, both delta and mu opioid receptors are
expressed in baskets cells that could receive TA inputs [18,29] but
no direct neuroanatomical connectivity has been demonstrated so
far. We thus took advantage of the DOR-eGFP knock-in mouse
and performed anterograde tracing experiments by injecting BDA
in the entorhinal cortex (Fig. 3A). Observation by confocal
microscopy of DOR-eGFP and BDA-associated fluorescence in
the stratum lacunosum-moleculare layer of three mice (Fig. 3B)
revealed that TA fibers and DOR-eGFP expressing neurites are
located in close vicinity, suggesting that synaptic contacts can
occur (Fig. 3C–F).
We then explored mu and delta modulation of interneurons
recruited by the TA pathway. This pathway is a branch of the
perforant path, entering the hippocampus via the subiculum and
directly contacting CA1. We performed TA stimulation in
horizontal slices, in which its integrity is better preserved than in
coronal slices. Stimulating electrode was placed in the stratum
lacunosum moleculare of the subiculum. Selectivity of the TA
recruitment was ensured by performing two additional cuts: one
between CA3 and CA1 to avoid activation of the Schaffer
collateral by the classical tri-synaptic pathway and the other in the
stratum radiatum between CA1 and the subiculum to prevent
stimulation from directly activating CA1 interneurons. Compar-
ison of the field potential changes evoked in the stratum
lacunosum-moleculare and stratum radiatum of CA1 upon SC
and TA stimulation indicated that such cuts efficiently prevented
antidromic SC stimulation from contaminating the TA-evoked
response (data not shown, and [30]). Whole-cell patch clamp
recording of pyramidal cells after TA stimulation showed eIPSC
with statistically longer peak latencies than eEPSC (14.163.8 ms
versus 9.660.7 ms, p = 0.035) suggesting a di-synaptic nature of
the TA eIPSC as expected, rather than a direct recruitment of
interneurons by the stimulation electrode, minimized by the cut
made in the stratum radiatum. This was further confirmed as
inhibiting the glutamatergic transmission between the TA pathway
and the interneurons by perfusion of the slice with a cocktail of
glutamatergic blockers (APV & CNQX 50 mM+Kynurenate
2 mM) successfully abolished most of the evoked current
(78.469.6% decrease, p = 0.029).
Application of the mu selective agonist DAGO (500 nM) or the
delta selective agonist deltorphin II (500 nM) both decreased
eIPSC amplitude (61.360.4% (n= 3) and 62.864.6% (n= 6)
respectively, Fig. 4A&B). The effect of deltorphin II on eIPSCs
could not be washed. This was unlikely due to an eIPSC run-down
since i) the effect of DAGO was partially reversed, and ii) a
decrease in eIPSC amplitude was not observed prior to deltorphin
II exposure, though we varied the time of application between 6
and 36 minutes after the start of the recording (data not shown).
To minimize exposure to deltorphin II, short applications (10 s)
were performed with a puff pipette next to the recorded pyramidal
cell. Under these conditions, TA eIPSC amplitude was decreased
by 37.665.2% and the effect could be fully washed out (n = 11,
Opioid Receptor Expressing Neurons in CA1 Network
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p,0.01). In half of the recordings, a cocktail of glutamatergic
blockers was also applied, which successfully abolished the
TAeIPSC, further confirming its di-synaptic nature (decrease of
83.567.8%). Control aCSF puff showed no significant modifica-
tion TAeIPSC amplitude (decrease of 2.365.6%, n=4) indicating
no mechanical effect of the pressure injection. On one cell
(Fig. 4C), we managed to switch the puff pipette twice during the
experiment with the aCSF puff having no effect (decrease of
0.9%), while following puffs of DAMGO and deltorphin II
reduced the TAeIPSC amplitude by 55.7% and 61.3%, respec-
tively. Altogether, data suggest that both mu and delta opioid
receptor expressing interneurons are recruited by the TA pathway.
Discussion
In this study, we examined mu and delta opioid receptor
modulation of both SC and TA pathways in the mouse CA1 area
by a combination of electrophysiology, anterograde labeling and
fluorescence confocal microscopy.
DOR-eGFP knock-in mice enable direct visualization of delta
opioid receptors with subcellular localization, which led to uncover
unexpected spontaneous receptor internalization during mouse
hippocampal slice preparation. Receptor internalization classically
occurs upon activation by an agonist [31]. In our slice preparation,
internalization may result from peptide release occurring after
slicing through opioidergic neurons or from ischemia leading to
Ca2+ entry, neuron depolarization and/or unspecific neuropeptide
release. We thus tested several strategies to prevent receptor
activation and subsequent internalization. Slice preparation in the
presence of naltrexone, a classical opioid antagonist, proved
inefficient. On the other hand, the internalization process was
slowed down by sucrose addition as shown previously for opioid
receptors in neuroblastoma cell lines [24] or neuronal cultures [25]
but neuron viability was deeply affected when slices were returned
from high sucrose to aCSF. Finally, sodium chloride substitution
with potassium-gluconate prevented delta opioid receptor inter-
nalization without alteration in cellular morphology or sIPSC
frequency. Indeed, this protocol transiently decreases the electrical
activity of the slice likely by limiting the entry of calcium and other
extracellular ions into neurons thereby keeping them slightly
hyperpolarized thus maximizing neuron survival [26].
Despite growing interest for the implication of opioid receptors
in learning and memory processes and drug-context associations
[7–10], few electrophysiological data are available regarding the
role of delta opioid receptors within the hippocampal circuitry.
Early studies by Lupica and coll. in rats observed that delta opioid
receptor activation, while inhibiting spontaneous inhibition
received by CA1 pyramidal cells, had no effect on SC mediated
feed-forward and recurrent inhibition, contrary to mu opioid
receptor activation [15,27]. This suggested a distinct distribution
of the two receptors among inhibitory interneurons in the rat
hippocampal network. Here, we found comparable results in mice,
indicating that the SC pathway is modulated by mu but not delta
receptors in both rodent species.
Most importantly, our data demonstrate that delta receptor
expressing neurons are recruited by the TA pathway. These
receptors could be expressed in a population of basket cells that
would not respond to SC stimulation but would selectively be
activated by the TA pathway. Additional experiments are however
required to unambiguously establish this point. The intrahippo-
campal trisynaptic loop constitutes a unidirectional route that
originates in the entorhinal cortex. Mossy fibers convey informa-
tion from the dentate gyrus to the CA3, then, SC fibers from the
CA3 to the CA1. The TA pathway, on the other hand, directly
Figure 2. Mu but not delta opioid receptor expressing interneurons are recruited by the SC pathway. The selective delta opioid
receptor agonist deltorphin II 500 nM reduces sIPSC frequency (A) but not SC-eIPSC amplitude (B). The selective mu agonist DAGO 500 nM decreases
both sIPSC frequency (C) and SC-eIPSC amplitude (D). Representative traces and corresponding time course. * or #, p,0.05, ** or ##, p,0.01 versus
baseline or drug respectively. Scale bar 50 pA/500 ms for sIPSC and 100 pA/10 ms for SC-eIPSC.
doi:10.1371/journal.pone.0079081.g002
Opioid Receptor Expressing Neurons in CA1 Network
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e79081
connects the entorhinal cortex to the CA1 by projecting on
pyramidal cells but also on interneurons of the stratum lacunosum-
moleculare and basket cells [29]. This entry has been much
studied in the context of epilepsy [32] and, more recently, was
shown to play a role in long-term memory consolidation [33] and
spatial representation processes [28]. Activation of the TA
pathway results in a net global inhibition of the pyramidal cells
preventing firing of action potentials [19]. In addition, inhibition
of the SC excitatory input by the TA pathway leads to reduced
CA1 cell firing [19]. Importantly, activation of mu opioid
receptors drastically modulates the TA inhibition exerted on the
SC input during theta rhythms [34]. Our data show for the first
time that this pathway is modulated by both mu and delta opioid
receptors.
The involvement of delta opioid receptors in TA rather than SC
pathway is intriguing. Recent evidence has indicated that delta
Figure 3. In the CA1 stratum lacunosum-moleculare, TA fibers and DOR-eGFP expressing neurites are in close vicinity. A: General
view of a coronal slice showing the tracer injection point in the entorhinal cortex (arrowhead) and fibers of the perforant path. Scale bar 100 mm. B:
Detail of the CA1 area delineated in A, showing TA projections (red) in the stratum lacunosum moleculare. Scale bar 100 mm. C–F: Representative
9mm thick Z projection (C) and single plan confocal images (D–F) from the zone delineated in B, showing close vicinity (arrowheads) between TA
fibers (red) and DOR-eGFP expressing neurites (green) in the stratum lacunosum-moleculare. Nuclei are stained with DAPI. Scale bar 10 mm.
doi:10.1371/journal.pone.0079081.g003
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opioid receptors are key players in drug-context-associations, and
likely facilitate this learning process (Marinelli et al., 2009, Le
Merrer et al., 2011). On the other hand, requirement of the TA
pathway for long-term spatial memory consolidation has been
established [35]. In the context of opioid abuse, chronic exposure
to morphine or heroin likely results in mu opioid receptor
desensitization [36] and, as a consequence, delta receptors may
become the main target for endogenous opioids in the CA1. We
may speculate that increased delta receptor function and the
subsequent asymmetric change in SC/TA activities could
reinforce the positive perception of environmental cues associated
with drug taking. The importance of delta receptors in those
processes, therefore, deserves further studies, and may open novel
perspectives in our understanding of hippocampal physiology and
opioid regulation of learning processes.
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